These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21087247)

  • 1. Development and reliability of a correction factor for parent-reported adherence to pediatric antiepileptic drug therapy.
    Modi AC; Guilfoyle SM; Morita DA; Glauser TA
    Epilepsia; 2011 Feb; 52(2):370-6. PubMed ID: 21087247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-month adherence in children with new-onset epilepsy: white-coat compliance does not occur.
    Modi AC; Morita DA; Glauser TA
    Pediatrics; 2008 Apr; 121(4):e961-6. PubMed ID: 18316355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White coat adherence over the first year of therapy in pediatric epilepsy.
    Modi AC; Ingerski LM; Rausch JR; Glauser TA; Drotar D
    J Pediatr; 2012 Oct; 161(4):695-9.e1. PubMed ID: 22608905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of nonadherence in children and adolescents with epilepsy: A multimethod assessment approach.
    Alsous M; Hamdan I; Saleh M; McElnay J; Horne R; Masri A
    Epilepsy Behav; 2018 Aug; 85():205-211. PubMed ID: 30032809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to antiepileptic drugs in adolescents with epilepsy.
    Smith AW; Mara CA; Modi AC
    Epilepsy Behav; 2018 Mar; 80():307-311. PubMed ID: 29429909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence barriers in pediatric epilepsy: From toddlers to young adults.
    Gutierrez-Colina AM; Smith AW; Mara CA; Modi AC
    Epilepsy Behav; 2018 Mar; 80():229-234. PubMed ID: 29433948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of nonadherence to antiepileptic drug therapy in children with newly diagnosed epilepsy.
    Modi AC; Rausch JR; Glauser TA
    JAMA; 2011 Apr; 305(16):1669-76. PubMed ID: 21521848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiepileptic drug behavioral side effects and baseline hyperactivity in children and adolescents with new onset epilepsy.
    Guilfoyle SM; Follansbee-Junger K; Smith AW; Combs A; Ollier S; Hater B; Modi AC
    Epilepsia; 2018 Jan; 59(1):146-154. PubMed ID: 29114859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Stability and Influence of Barriers to Medication Adherence on Seizure Outcomes and Adherence in Children With Epilepsy Over 2 Years.
    Ramsey RR; Zhang N; Modi AC
    J Pediatr Psychol; 2018 Mar; 43(2):122-132. PubMed ID: 29049791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supporting treatment adherence regimens in children with epilepsy: A randomized clinical trial.
    Modi AC; Guilfoyle SM; Glauser TA; Mara CA
    Epilepsia; 2021 Jul; 62(7):1643-1655. PubMed ID: 33982280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral predictors of medication adherence trajectories among youth with newly diagnosed epilepsy.
    Loiselle K; Rausch JR; Modi AC
    Epilepsy Behav; 2015 Sep; 50():103-7. PubMed ID: 26209946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allocation of Treatment Responsibility in Adolescents With Epilepsy: Associations With Cognitive Skills and Medication Adherence.
    Holbein CE; Smith AW; Peugh J; Modi AC
    J Pediatr Psychol; 2019 Jan; 44(1):72-83. PubMed ID: 29447360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uninformed clinical decisions resulting from lack of adherence assessment in children with new-onset epilepsy.
    Modi AC; Wu YP; Guilfoyle SM; Glauser TA
    Epilepsy Behav; 2012 Dec; 25(4):481-4. PubMed ID: 23159375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of the Pediatric Epilepsy Medication Self-Management Questionnaire.
    Modi AC; Monahan S; Daniels D; Glauser TA
    Epilepsy Behav; 2010 May; 18(1-2):94-9. PubMed ID: 20452831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric patients with undetectable anticonvulsant blood levels: comparison with compliant patients.
    Snodgrass SR; Vedanarayanan VV; Parker CC; Parks BR
    J Child Neurol; 2001 Mar; 16(3):164-8. PubMed ID: 11305683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary feasibility and efficacy of text messaging and application-based adherence interventions in adolescents with epilepsy.
    Modi AC; Mann KA; Urso L; Peugh J
    Epilepsy Behav; 2016 Oct; 63():46-49. PubMed ID: 27565437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to antiepileptic medicines in children: a multiple-methods assessment involving dried blood spot sampling.
    Shah NM; Hawwa AF; Millership JS; Collier PS; Ho P; Tan ML; Peake D; Tirupathi S; Bothwell J; Bailie N; Shepherd C; Craig J; McElnay JC
    Epilepsia; 2013 Jun; 54(6):1020-7. PubMed ID: 23448146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vulnerabilities to antiepileptic drug (AED) side effects in youth with epilepsy.
    Wagner JL; Mueller M; Kellermann T; Griffin M; Smith G; Soliven M; Guilfoyle SM; Junger KF; Mucci G; Huszti H; Barrett L; Zupanc M; Modi AC
    Epilepsy Behav; 2019 Aug; 97():22-28. PubMed ID: 31181425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and reliability of a correction factor for family-reported medication adherence: pediatric inflammatory bowel disease as an exemplar.
    Wu YP; Pai AL; Gray WN; Denson LA; Hommel KA
    J Pediatr Psychol; 2013 Sep; 38(8):893-901. PubMed ID: 23804406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary feasibility, acceptability, and efficacy of an innovative adherence intervention for children with newly diagnosed epilepsy.
    Modi AC; Guilfoyle SM; Rausch J
    J Pediatr Psychol; 2013 Jul; 38(6):605-16. PubMed ID: 23613481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.